Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1995-06-05
1998-08-04
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
424 165, 424 111, 534 14, 530300, A61K 5100, A61M 3614
Patent
active
057889600
ABSTRACT:
The invention relates to radiolabeled imaging of a mammalian body. The invention in particular provides for reagents labeled with technetium-99 m for such imaging. The invention provides peptides which bind technetium-99 m and which can be targeted to specific sites within a mammalian body.
REFERENCES:
patent: 4434151 (1984-02-01), Byrne et al.
patent: 4444690 (1984-04-01), Fritzberg et al.
patent: 4472509 (1984-09-01), Gansow et al.
patent: 4571430 (1986-02-01), Byrne et al.
patent: 4575556 (1986-03-01), Byrne et al.
patent: 4578079 (1986-03-01), Rouslhati et al.
patent: 4729525 (1988-03-01), Rouslhati et al.
patent: 4857508 (1989-08-01), Adams et al.
patent: 4861869 (1989-08-01), Nicolotti et al.
patent: 4986979 (1991-01-01), Morgan, Jr. et al.
patent: 5086069 (1992-02-01), Klein et al.
patent: 5102990 (1992-04-01), Rhodes
patent: 5443816 (1995-08-01), Zamora et al.
patent: 5449761 (1995-09-01), Belinka, Jr. et al.
patent: 5506208 (1996-04-01), Eyal et al.
patent: 5508020 (1996-04-01), Dean et al.
patent: 5552525 (1996-09-01), Dean
patent: 5561220 (1996-10-01), Dean et al.
Pearson et al (1996). J. Med. Chem. vol. 39, No. 7, pp. 1372-1382, Thrombus Imaging Using Technetium-99m Labeled High Potency GPII/III a Receptor, Antagonists. Chemsitry and Initial Biological Studies.
Rhodes, 1974, "Considerations in the Radiolabeling of Albumin", Sem. Nucl. Med. 4:281-293.
Davidson et al., 1981, "A New Class of Oxotechnetium(5+) Chelate Complexes containing a TcON.sub.2 S.sub.2 Core", Inorg. Chem. 20:1629-1632.
Fritzberg et al., 1982, "Synthesis and Biological Evaluation of Tc-99m N,N'-Bis(mercaptoacetyl)-2,3-diaminopropanoate: A Potential Replacement
Fritzberg et al., 1982, "Clinical comparison of Tc-99m N,N'-bis(mercaptoacetamido)ethylenediamine and (.sup.131 I) ortho-iodohippurate for evaluation of renal tubular function:Concise Communication", J. Nucl. Med. 23:P17.
Khaw et al., 1982, "Technetium-99m Labeling of Antibodies to Cardiac Myosin Fab and to Human Fibrinogen", J. Nucl. Med. 23:1011-1019.
Byrne and Tolman, 1983, "Technetium-99m Bifunctional Chelating Agent--Thiolactone for Coupling to Biomolecules, N.sub.2 S.sub.2 Ligand for Chelation to Technetium", J. Nucl. Med. 24:P126.
Bryson et al., 1988, "Neutral Technetium(V) Complexes with Amide-Thiol-Thioether Chelating Ligands", Inorg. Chem. 27:2154-2161.
Bryson et al., 1990, "Protecting Groups in the Preparation of Thiolate Complexes of Technetium", Inorg. Chem. 29:2948-2951.
Knight et al., 1990, "Thrombus Imaging with Tc-99m Synthetic peptides Reactive with Activated Platelets", J. Nucl. Med. 31:757#209.
Deuel et al., 1977, Proc. Natl. Acad. Sci. USA 74:2256-2258 disclose the amino acid sequence of human platelet factor 4.
Niedel and Cuatrecasas, 1980, Formyl Peptide Chemotactic Receptors of Leukocytes and Macrophages, in Curr. Top. Cell. Reg. 17: 137-170.
Deuel et al., 1981, Proc. Natl. Acad. Sci. USA 78:4584-4587 disclose that platelet factor 4 is chemotactic for neutrophils and monocytes in vitro.
Zoghbi et al., 1981, J. Nucl. Med. 22:32 (Abst) disclose formyl peptide chemotactic factors (fMLF) derived from bacteria coupled to .sup.111 In-labeled transferrin.
Jiang et al., 1982, Nuklearmedizin 21:110-113 disclose a chemotactic formylated peptide (fMLF) radiolabeled with .sup.125 I.
Osterman et al., 1982, Biochem. Biophys. Res. Comm. 107: 130-135 disclose that the carboxyl-terminal tridecapeptide of platelet factor 4 has chemotactic properties.
Holt & Niewiarowski, 1985, Sem. Hematol. 22:151-163 biochemistry of platelet .alpha.-granule proteins.
Goldman et al., 1985, Immunol. 54:163-171, Inhibition of human neutrophilreceptor-medicated uptake of N-formyl-met-leu-phe by platelet factor 4 (59-70).
Loscalzo et al., 1985, Arch. Biochem. Biophys. 240: 446-455 The interaction between platelet factor 4 and glycosaminoglycans.
Bebawy et al., 1986, J. Leukocyte Biol. 39:423-434, In Vitro Effects of Platelet Factor 4 on Normal Human Neutrophil Functions.
Wilkinson, 1988, Meth. Enzymol. 162:127-132 a method for characterizing chemotactic peptides capable of causing leukocytes to move up a peptide concentration gradient.
Vorne et al., 1989, J. Nucl. Med. 30:1332-1336 Tc-99m labeled luekocytes for imaging sites of infection.
LaMuraglia et al., 1989, J. Vasc. Surg. 10:20-28 .sup.111 In-labeled non-specific human immunoglobulin to detect sites of inflammation in vivo.
Maione et al., 1989, Science 247:77-79 Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides.
Lind et al., 1990, J. Nucl. Med. 31:417-473 Tc-99m labeled antigranulocyte monoclonal antibodies to detect inflammation.
Fischman et al., 1991, J. Nucl. Med. 32:482-491 chemotactic formyl peptide (fMLF)--.sup.111 In-labeled DTPA conjugates.
Hartman et al., 1992, "Non-peptide fibrinogen receptor antagonists: 1. Discovery and design of exosite inhibitors", J. Med. Chem. 35:4640-4642.
Ojima et al., 1992, "Design and Synthesis of New RGD Peptides as Inhibitors of Human Platelet Aggregation", 204th Meeting, Amer. Chem. Soc. Abst. 44.
Knight, 1990, "Radiopharmaceuticals for Thrombus Detection", Sem. Nucl. Med. 20:52-67.
Plow et al., 1987, in Perspectives in Inflammation, Neoplasia and Vascular Cell Biology, pp. 267-275, Interaction of Adhesive Proteins with Platelets .
Diatech Inc.
Hollinden Gary E.
Jones Dameron
LandOfFree
Technetium-99M labeled polypeptides for imaging does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Technetium-99M labeled polypeptides for imaging, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Technetium-99M labeled polypeptides for imaging will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1174286